WHO ICTRP trial
Does continuous cefotaxime administration improve time to attainment and…
NL-OMON41771 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON41771 |
|---|---|
| Public title | Does continuous cefotaxime administration improve time to attainment and maintenance of target drug levels in intensive care patients? |
| Scientific title | Does continuous cefotaxime administration improve time to attainment and maintenance of target drug levels in intensive care patients? - Cefotaxime target attainment |
| Primary sponsor | Universitair Medisch Centrum Groningen |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Countries | The Netherlands |
| Conditions | bacterial pneumonia selective decontamination of the digestive tract;10004018;bacterial pneumonia;selective decontamination of the digestive tract |
| Interventions | ;Cefotaxime;critical care;pharmacokinetics;target attainment |
| Registration date | Jun 18, 2015 |
| Target size | 60 |
| Secondary IDs | NL50809.042.14 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: